A global meta-analysis finds that anemia affects 37% of patients with inflammatory bowel disease, highlighting gaps in ...

It can be overwhelming to receive a diagnosis of inflammatory bowel disease (IBD), a condition which refers to the chronic diseases that can cause inflammation in your gastrointestinal (GI) tract.

The use of glucagon-like peptide 1 (GLP-1) receptor agonists is associated with a reduced risk for poor inflammatory bowel disease (IBD)–related outcomes in patients with both IBD and type 2 diabetes ...

Patients with inflammatory bowel disease (IBD) have a 48% greater relative risk of developing interstitial lung disease (ILD) than the general population. Among IBD patients, women, older adults, and ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Patients infected with SARS-CoV-2 during the first wave ...

Please provide your email address to receive an email when new articles are posted on . The incidence of inflammatory bowel disease is 10.9 per 100,000 person-years and peaks in the third decade of ...

In successful clinical trials of drugs for inflammatory bowel disease (IBD), patients who received a placebo were at significantly higher risk for potential harms, according to two systematic reviews.

Sustainable IBD care requires improving access to cost-effective treatments, increasing biosimilar uptake, and implementing multidisciplinary strategies to reduce expenses. Direct costs of IBD care ...